Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease (Q39365419)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease |
scientific article |
Statements
1 reference
Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease (English)
1 reference
1 reference
Paolo Urbani
1 reference
José Antonio Ramos
1 reference
Javier Fernández-Ruiz
1 reference
1 July 2005
1 reference
1 reference
Identifiers
1 reference